Familial isolated pituitary adenomas experience at a single center: Clinical importance of AIP mutation screening;Experiência de um único centro em adenoma hipofisário familiar isolado: Importância clínica do rastreio de mutação do AIP

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 8, 2010, Pages 698-704

  de Pinho, Leandro Kasuki Jomori ^a,b   Neto, Leonardo Vieira ^a,c   Wildemberg, Luiz Eduardo Armondi ^a   Moraes, Aline Barbosa ^a,b   Takiya, Christina M ^a   Frohman, Lawrence A ^d   Korbonits, Márta ^e,f   Gadelha, Mônica R ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

^c HOSPITAL DA LAGOA   (Brazil)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; SIGNAL PEPTIDE;

ACROMEGALY; ADENOMA; ADULT; ARTICLE; CASE REPORT; FAMILY; FEMALE; GENETICS; HUMAN; HYPOPHYSIS TUMOR; MALE; MIDDLE AGED; MUTATION; PROLACTINOMA;

ACROMEGALY; ADENOMA; ADULT; FAMILY; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; PITUITARY NEOPLASMS; PROLACTINOMA; YOUNG ADULT;

EID: 79951999077     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000800006     Document Type: Article

References (20)

1. Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab. 2010;21(7):419-27.
2. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. 2007;157(4):371-82.
3. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab. 2006;91(9):3316-23.
4. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A. 2006;103(42):15558-63.
5. Gadelha MR, Prezant TR, Une KN, Glick RP, Moskal SF 2nd, Vaisman M, et al. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab. 1999;84(1):249-56.
6. Benlian P, Giraud S, Lahlou N, Roger M, Blin C, Holler C, et al. Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family. Eur J Endocrinol. 1995;133(4):451-6.
7. Yamada S, Yoshimoto K, Sano T, Takada K, Itakura M, Usui M, et al. Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1997;82(1):239-42.
8. Tanaka C, Yoshimoto K, Yamada S, Nishioka H, Li S, Moritani M, et al. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endocrinol Metab. 1998;83(3):960-5.
9. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab. 2000;85(2):707-14.
10. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006;312(5777):1228-30.
11. Cazabat L, Guillaud-Bataille M, Bertherat J, Raffin-Sanson ML. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas. Horm Res. 2009;71(3):132-41.
12. Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 2010;31(8):950-60.
13. Gadelha MR, Frohman LA. Pathogenesis of familial acromegaly. Front Horm Res. 2010;38:121-6.
14. Georgitsi M, Heliövaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, et al. Large genomic deletions in AIP in pituitary adenoma predisposition. J Clin Endocrinol Metab. 2008;93(10):4146-51.
15. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab. 2008;93(6):2390-401.
16. Murray RD, Melmed S. A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. J Clin Endocrinol Metab. 2008;93(8):2957-68.
17. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, et al. Mutations in the aryl hydrocarbon receptor in-teracting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab. 2007;92:1952-5.
18. Raitila A, Georgitsi M, Karhu A, Tuppurainen K, Makinen MJ, Birkenkamp-Demtroder K, et al. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocrine-Related Cancer. 2007;14(3):901-6.
19. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, et al. Germline inactivating mutations FIPA experience at a single center of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol. 2007;157(1):1-8.
20. Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet. 2010;78(5):457-63.